Randomized, open-label, tolterodine-controlled, comparative study of the novel antimuscarinic agent imidafenacin in Caucasian patients with overactive bladder
Kasyan, G.R., Kolontarev, K.B., Pushkar, D.Y.Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)31440-X
Date:
March, 2019
File:
PDF, 86 KB
2019